Which has grown faster, INMD or LXRX?

Over the past five years, LXRX grew revenue faster — INMD at a 5.42% CAGR versus LXRX at 42.36%.

Is INMD or LXRX more profitable?

INMD runs the higher net margin — INMD at 20.69% versus LXRX at -147.38%.

How have INMD and LXRX total returns compared?

Over the past 5 years, INMD delivered -27.48% and LXRX delivered -18.54% annualized total return. Past performance doesn't predict future results.

InMode Ltd. (INMD) vs Lexicon Pharmaceuticals, Inc. (LXRX)

A side-by-side comparison of InMode Ltd. and Lexicon Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

INMD

InMode Ltd.

$809M

$14.07HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT

LXRX

Lexicon Pharmaceuticals, Inc.

$769M

$1.73HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT

Total return — INMD vs LXRX

growth of $100 · dividends reinvested · last 7y

INMD +108.1% (+11.0%/yr)LXRX +32.8% (+4.1%/yr)INMD compounded faster over this window

INMD LXRX

INMD vs LXRX: by the numbers

•INMD is the larger company ($809M vs $769M market cap).
•INMD is profitable (20.69% net margin) while LXRX runs a net loss (-147.38%).
•LXRX grew revenue faster over the past five years (42.36% vs 5.42% CAGR).

Metrics side by side

Valuation

Metric	INMD	LXRX
P/E ratio	11.44	N/A
Forward P/E	10.86	N/A
PEG ratio	1.15	N/A
P/S ratio	2.16	18.53
P/B ratio	1.29	4.40
EV / EBITDA	5.97	N/A
FCF yield	10.81%	N/A

Profitability

Metric	INMD	LXRX
Gross margin	76.52%	98.85%
Operating margin	18.47%	-98.21%
Net margin	20.69%	-147.38%
ROE	12.32%	-35.02%
ROIC	9.20%	-23.16%

Growth (annualized)

Metric	INMD	LXRX
Revenue CAGR (5Y)	5.42%	42.36%
EPS CAGR (5Y)	6.87%	N/A
FCF CAGR (5Y)	1.36%	N/A
Total return CAGR (5Y)	-27.48%	-18.54%

Frequently asked

Which has grown faster, INMD or LXRX?: Over the past five years, LXRX grew revenue faster — INMD at a 5.42% CAGR versus LXRX at 42.36%.
Is INMD or LXRX more profitable?: INMD runs the higher net margin — INMD at 20.69% versus LXRX at -147.38%.
How have INMD and LXRX total returns compared?: Over the past 5 years, INMD delivered -27.48% and LXRX delivered -18.54% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INMD analysis Full LXRX analysis Interactive comparison tool

Dig into the metrics

InMode P/E ratio InMode ROE Lexicon Pharmaceuticals ROE InMode operating margin Lexicon Pharmaceuticals operating margin InMode revenue growth Lexicon Pharmaceuticals revenue growth InMode free cash flow Lexicon Pharmaceuticals free cash flow

InMode & Lexicon Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.